Evidence map›Paper›PMID 42368789›Full record

ArticleInternational journal of breast cancer2026

Comparing Disease-Free Survival (DFS) and Overall Survival (OS) Rates in Breast Cancer Patients: Axillary Lymph Node Dissection (ALND) Versus Sentinel Lymph Node Biopsy (SLNB).

Bahar Amiri, Mahta Mellat Ardakani, Ali Pajouhi, Atieh Akbari, Simin Farokhi, Mohammad Esmaeil Akbari, Samaneh Tahmasebi Ghorabi, Arian Karimi Rouzbahani, Mania Beiranvand

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of breast cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Bahar AmiriStudent Research Committee, Faculty of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran, lums.ac.ir.ORCID https://orcid.org/0009-0008-1842-1520
Mahta Mellat ArdakaniStudent Research Committee, Faculty of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran, lums.ac.ir.
Ali PajouhiStudent Research Committee, Faculty of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran, lums.ac.ir.ORCID https://orcid.org/0000-0002-5445-4951
Atieh AkbariCancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran, sbmu.ac.ir.ORCID https://orcid.org/0000-0001-5628-0409
Simin FarokhiRazi Herbal Medicines Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran, lums.ac.ir.ORCID https://orcid.org/0000-0002-7853-8834
Mohammad Esmaeil AkbariCancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran, sbmu.ac.ir.ORCID https://orcid.org/0000-0002-9938-3587
Samaneh Tahmasebi GhorabiUSERN Office, Lorestan University of Medical Sciences, Khorramabad, Iran, lums.ac.ir.ORCID https://orcid.org/0000-0002-6448-9664
Arian Karimi RouzbahaniRazi Herbal Medicines Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran, lums.ac.ir.ORCID https://orcid.org/0000-0002-0239-503X
Mania BeiranvandCancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran, sbmu.ac.ir.ORCID https://orcid.org/0000-0003-0076-4994

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Examining the survival rate in breast cancer patients serves as a metric for assessing and advancing various treatment modalities. In light of the significant incidence of breast cancer in Iran, this study is aimed at examining and comparing the disease-free survival (DFS) and overall survival (OS) rates among breast cancer patients who underwent axillary lymph node dissection (ALND) and sentinel lymph node biopsy (SLNB). Patients and Methods: This retrospective cohort research included 1071 patients at Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran, from 1991 to 2021. The recurrence and survival rates of patients undergoing ALND and SLNB in both groups were examined and evaluated. The data were analyzed using SPSS statistical software using descriptive statistical techniques (percentage, frequency, mean, and standard deviation), Kaplan-Meier analysis, and Cox regression tests. A significance threshold of 0.05 is used. Results: The average OS among all patients was 18.08 ± 0.51. The average OS in the ALND group was 18.1 ± 0.53; in the SLNB group, it was 12.8 ± 0.39, which was insignificant ( Conclusion: OS and DFS in the ALND group were higher than in the SLNB group, but they were not statistically significant.

Indexed as

ALNDbreast cancerdisease-free survivaloverall survivalSLNB

Identifiers

PMID42368789
PMCPMC13305675

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.